Millennium Management LLC 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-17 4:34 pm Sale | 2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR | Millennium Management LLC | 3,403,530 1.700% | -6,772,999 (-66.56%) | Filing |
| 2024-06-12 4:26 pm Purchase | 2024-06-10 | 13G | Esperion Therapeutics, Inc. ESPR | Millennium Management LLC | 10,176,529 5.400% | 6,532,578 (+179.27%) | Filing |
| 2024-01-17 5:01 pm Sale | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Millennium Management LLC | 3,643,951 3.200% | -1,722,501 (-32.10%) | Filing |
| 2023-08-29 4:17 pm Purchase | 2023-08-28 | 13G | Esperion Therapeutics, Inc. ESPR | Millennium Management LLC | 5,366,452 5.000% | 143,013 (+2.74%) | Filing |
| 2023-08-28 4:13 pm Purchase | 2023-08-21 | 13G | Esperion Therapeutics, Inc. ESPR | Millennium Management LLC | 5,223,439 4.900% | 1,599,537 (+44.14%) | Filing |
| 2023-01-20 4:13 pm Purchase | 2023-01-11 | 13G | Esperion Therapeutics, Inc. ESPR | Millennium Management LLC | 3,623,902 4.900% | 3,623,902 (New Position) | Filing |